Fidelity Investments’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1
Closed -$1 5777
2023
Q3
$1 Buy
+1
New +$1 ﹤0.01% 5264
2022
Q4
Sell
-4,683
Closed -$63K 5713
2022
Q3
$63K Sell
4,683
-1,021
-18% -$51.6K ﹤0.01% 3411
2022
Q2
$1.4M Hold
5,704
﹤0.01% 2593
2022
Q1
$1.67M Hold
5,704
﹤0.01% 2662
2021
Q4
$1.2M Hold
5,704
﹤0.01% 2655
2021
Q3
$1.85M Hold
5,704
﹤0.01% 2583
2021
Q2
$2.01M Hold
5,704
﹤0.01% 2549
2021
Q1
$2.19M Buy
5,704
+2,500
+78% +$1.08M ﹤0.01% 2456
2020
Q4
$1.29M Buy
3,204
+2,465
+334% +$1.07M ﹤0.01% 2480
2020
Q3
$312K Buy
+739
New +$335K ﹤0.01% 2622

Other funds holding CFRX

Fidelity Investments's CFRX Position: Q4 2023 in Review

Fidelity Investments sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 1 share — an estimated $1 sold.

Fidelity Investments first reported a position in CFRX in Q3 2020 and held it in 10 quarters. The position peaked at $2.19M in Q1 2021. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.

  • Fidelity Investments reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
  • Fidelity Investments sold 1 ContraFect Corporation share in Q4 2023, an estimated $1.
  • Fidelity Investments first reported a position in ContraFect Corporation in Q3 2020 and held it in 10 quarters.
  • Fidelity Investments's ContraFect Corporation position peaked at $2.19M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.